MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: H. Lundbeck A/S
• Treatments: Gaboxadol

Criteria

Inclusion Criteria:

• Patients with a diagnosis of primary insomnia

Exclusion Criteria:

• Patients with an active psychiatric disorder other than primary insomnia